<ix:nonnumeric contextref="c-1" continued-fact="false" enabled-fact="true" escape="true" hover-fact="false" id="fact-identifier-1487" inside-table="false" ix="f-1267" name="ba:ScheduleOfInvestmentsTableTextBlock" selected-fact="false"><div><span>Our investments, which are recorded in Short-term and other investments or Investments, consisted of the following at December 31:</span></div><div><table><tbody><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="3"></td><td colspan="3"><span>2024</span></td><td colspan="3"><span> </span></td><td colspan="3"><span>2023</span></td></tr><tr><td colspan="3"><div><span>Time deposits </span><span>(1)</span></div></td><td colspan="2"><span>$<ix:nonfraction contextref="c-15" decimals="-6" format="ixt:num-dot-decimal" id="fact-identifier-1488" inside-table="true" ix="f-1268" name="us-gaap:OtherShortTermInvestments" scale="6" unitref="usd">11,960</ix:nonfraction></span><span> </span></td><td></td><td colspan="3"></td><td colspan="2"><span>$<ix:nonfraction contextref="c-16" decimals="-6" format="ixt:num-dot-decimal" id="fact-identifier-1489" inside-table="true" ix="f-1269" name="us-gaap:OtherShortTermInvestments" scale="6" unitref="usd">2,753</ix:nonfraction> </span></td><td></td></tr><tr><td colspan="3"><div><span>Equity method investments </span><span>(2)</span></div></td><td colspan="2"><span><ix:nonfraction contextref="c-15" decimals="-6" id="fact-identifier-1490" inside-table="true" ix="f-1270" name="us-gaap:EquityMethodInvestments" scale="6" unitref="usd">948</ix:nonfraction></span><span> </span></td><td></td><td colspan="3"></td><td colspan="2"><span><ix:nonfraction contextref="c-16" decimals="-6" id="fact-identifier-1491" inside-table="true" ix="f-1271" name="us-gaap:EquityMethodInvestments" scale="6" unitref="usd">966</ix:nonfraction> </span></td><td></td></tr><tr><td colspan="3"><div><span>Available-for-sale debt investments </span><span>(1)</span></div></td><td colspan="2"><span><ix:nonfraction contextref="c-15" decimals="-6" id="fact-identifier-1498" inside-table="true" ix="f-1272" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">517</ix:nonfraction></span><span> </span></td><td></td><td colspan="3"></td><td colspan="2"><span><ix:nonfraction contextref="c-16" decimals="-6" id="fact-identifier-1499" inside-table="true" ix="f-1273" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" unitref="usd">499</ix:nonfraction> </span></td><td></td></tr><tr><td colspan="3"><span>Equity and other investments</span></td><td colspan="2"><span><ix:nonfraction contextref="c-15" decimals="-6" id="fact-identifier-1500" inside-table="true" ix="f-1274" name="us-gaap:OtherInvestments" scale="6" unitref="usd">34</ix:nonfraction></span><span> </span></td><td></td><td colspan="3"></td><td colspan="2"><span><ix:nonfraction contextref="c-16" decimals="-6" id="fact-identifier-1501" inside-table="true" ix="f-1275" name="us-gaap:OtherInvestments" scale="6" unitref="usd">69</ix:nonfraction> </span></td><td></td></tr><tr><td colspan="3"><div><span>Restricted cash &amp; cash equivalents </span><span>(1)(3)</span></div></td><td colspan="2"><span><ix:nonfraction contextref="c-15" decimals="-6" id="fact-identifier-807" inside-table="true" ix="f-1276" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" unitref="usd">21</ix:nonfraction></span><span> </span></td><td></td><td colspan="3"></td><td colspan="2"><span><ix:nonfraction contextref="c-16" decimals="-6" id="fact-identifier-808" inside-table="true" ix="f-1277" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" unitref="usd">22</ix:nonfraction> </span></td><td></td></tr><tr><td colspan="3"><span>Total</span></td><td colspan="2"><span>$<ix:nonfraction contextref="c-15" decimals="-6" format="ixt:num-dot-decimal" id="fact-identifier-1502" inside-table="true" ix="f-1278" name="us-gaap:Investments" scale="6" unitref="usd">13,480</ix:nonfraction></span><span> </span></td><td></td><td colspan="3"></td><td colspan="2"><span>$<ix:nonfraction contextref="c-16" decimals="-6" format="ixt:num-dot-decimal" id="fact-identifier-1503" inside-table="true" ix="f-1279" name="us-gaap:Investments" scale="6" unitref="usd">4,309</ix:nonfraction> </span></td><td></td></tr></tbody></table></div><div><span>(1)</span><span>Primarily included in Short-term and other investments on our Consolidated Statements of Financial Position.</span></div><div><span>(2)</span><span>Dividends received were $<ix:nonfraction contextref="c-1" decimals="-6" id="fact-identifier-1504" inside-table="false" ix="f-1280" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" unitref="usd">55</ix:nonfraction> and $<ix:nonfraction contextref="c-13" decimals="-6" id="fact-identifier-1505" inside-table="false" ix="f-1281" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" unitref="usd">31</ix:nonfraction> during 2024 and 2023. Retained earnings at December 31, 2024 and 2023 include undistributed earnings from our equity method investments of $<ix:nonfraction contextref="c-15" decimals="-6" id="fact-identifier-1506" inside-table="false" ix="f-1282" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" unitref="usd">141</ix:nonfraction> and $<ix:nonfraction contextref="c-16" decimals="-6" id="fact-identifier-1507" inside-table="false" ix="f-1283" name="us-gaap:RetainedEarningsUndistributedEarningsFromEquityMethodInvestees" scale="6" unitref="usd">110</ix:nonfraction>. </span></div><div><span>(3)</span><span>Reflects amounts restricted in support of our workers’ compensation programs and insurance premiums.</span></div></ix:nonnumeric>